Skip to main content

Table 2 Assesment of outcomes according to groups and total number of patients

From: The effectiveness of lixisenatide as an add on therapy to basal insulin in diabetic type 2 patients previously treated with different insulin regimes: a multi-center observational study

Type of insulin regime

Outcome

n

%

p value

Premix

Decrease in both BMI and HbA1c < 7%

15

13.5

 

Decrease in body weight

45

40.9

NS

Decrease in HbA1c < 7

16

14.5

 

Basal

Decrease in both BMI and HbA1c < 7%

10

9

 

Decrease in body weight

39

35.5

NS

Decrease in HbA1c < 7

13

11.8

 

Basal bolus

Decrease in both BMI and HbA1c < 7%

5

4.5

 

Decrease in body weight

15

13.5

NS

Decrease in HbA1c < 7

5

4.5

 
  1. BMI body mass index, NS not significant